 Sulfadiazine crystalluria treatment Toxoplasma encephalitis patients acquired immunodeficiency syndrome Toxoplasma gondii encephalitis important opportunistic infection acquired immunodeficiency syndrome patients acquired immunodeficiency syndrome United combination sulfadiazine pyrimethamine treatment choice Acute renal failure due crystal deposition urinary tract described years likely clinical entity appropriate prophylactic measures cases sulfadiazine-induced crystalluria renal failure patients acquired immunodeficiency syndrome pertinent literature pathogenesis Recommendations prophylaxis treatment sulfadiazine-related renal toxic reaction new drug aware potential danger sulfonamide-induced injury urinary tract